Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

3yrs ago Cannabis greenmarketreport Views: 409

-

Launches First-in-the-State Medical Cannabis Product 

Scientifically Formulated for Autism Patients of All Ages

NEW ORLEANS (LA) October 1, 2020 /AxisWire/ Louisiana-based Ilera Holistic Healthcare is pleased to announce the statewide launch of the HOPE - line of medical cannabis tinctures based on groundbreaking scientific research on using cannabis to treat the symptoms of autism spectrum disorder (ASD) in both children and adults.

Grown, cultivated, processed and packaged in Louisiana through a partnership between Ilera Holistic and Southern University’s Agricultural Center, HOPE - products are available exclusively through state-licensed MMJ pharmacies and available to all Louisiana patients and families through a doctor’s prescription. 

“After seeing the success of HOPE - in Pennsylvania, we were determined to bring it to patients of Louisiana, a state where we exceed the national percentage of autism diagnoses–while at-risk and under-served patients still struggle to receive safe and effective healthcare,” says Ilera Holistic CEO Dr. Chanda Macias. “Louisiana families deserve full access to all the benefits that cannabis medicine can provide, and we are thrilled to have HOPE in this market and available to everyone.”

Scientific research shows cannabis to be safe and effective on patients (including children) to treat ASD, and patients who use it have reported significant improvement in quality of life, mood, and sleep–and less reliance on other medications. 

HOPE - is the brainchild of Erica Daniels, founder of Hope Grows for Autism, a nonprofit aimed at improving the lives of families affected by autism through research, education and advocacy of medical marijuana.

“The autism community in Louisiana is blessed to have a partner in Ilera Holistic Healthcare to bring HOPE - to families affected by ASD,” says Daniels. “Now more than ever,  patients are struggling with the symptoms associated with autism. I am so thrilled that Ilera Holistic Healthcare is bringing HOPE - to so many Louisiana patients who need it!”

“HOPE - is another product with which we are proud to be associated,” said Janana Snowden, director of the Southern Institute for Medicinal Plants at the Southern University Agricultural Research and Extension Center. “The work we do aims to not only provide valuable research but to also provide potentially beneficial and accessible treatments for symptoms due to conditions that thousands of people live with daily, like autism.”

HOPE - was formulated by Zelira Therapeutics, a leading global therapeutic medical cannabis company with access to the world’s largest and fastest growing cannabis markets. The company’s focus is on developing branded cannabis products for the treatment of a variety of medical conditions including insomnia, autism and chronic non-cancer pain.

HOPE - is gluten, dairy, soy and nut-free; scientifically formulated, lab tested, and pesticide free; and only available in the state of Louisiana at licensed cannabis pharmacies. HOPE - will be available in two formulations: “HOPE1,” a 1:1 THC:CBD tincture, and “HOPE2”, a 5:1 THC:CBD tincture. 

About Ilera Holistic Healthcare 

Ilera Holistic Healthcare is a fully integrated medical marijuana company that fuses science and innovation to discover life-changing therapies. In Louisiana, we partner our world-class cultivation and extraction methods with Southern University’s to expertly create and deliver consistent, high quality medicines. From seed and soil to dispensary shelves, Ilera is committed to providing a superior health and wellness experience. 

 

###

 

ILERA HOLISTIC HEALTHCARE BRINGS HOPE™ TO PATIENTS IN LOUISIANA on Green Market Report.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.